Fanconi anemia and RAD50 deficiency [Elektronische Ressource] : genetic and functional analysis / vorgelegt von Reinhard Kalb

Sujets

• Gesundheit

Informations

• Publié par: julius-maximilians-universitat_wurzburg
• Publié le: 01 janvier 2006
• Nombre de lectures: 8
• Langue: English
• Poids de l'ouvrage: 3 Mo

Extrait

Fanconi anemia and RAD50 deficiency:
genetic and functional analysis
Dissertation zur Erlangung
des naturwissenschaftlichen Doktorgrades der
Bayerischen Julius-Maximilians-Universität Würzburg
vorgelegt von
Reinhard KalbFanconi anemia and RAD50 deficiency:
genetic and functional analysis
Dissertation zur Erlangung
des naturwissenschaftlichen Doktorgrades der
Bayerischen Julius-Maximilians-Universität Würzburg
vorgelegt von
Reinhard Kalb
-geboren in Bamberg-
Würzburg, Oktober 2006Eingereicht am 09. Oktober 2006
bei der Fakultät für Biologie
der Bayerischen Julius-Maximilians-Universität Würzburg
Mitglieder der Promotionskomission:
Vorsitzender: Prof. Dr. M.J. Müller
1. Gutachter: Prof. Dr. H. Höhn
2. Gutachter: Prof. Dr. E. Buchner
Tag des Promotionskolloquiums:
Doktorurkunde ausgehändigt am:“When we find a reason to live,
the way to do will follow”
(Mahatma Gandhi)CONTENTS III
CONTENTS
A) Preface and thesis outline 1-2
B) Introduction
CHAPTER 1
Fanconi Anemia: Consequences of Genetic Instability 3-19
CHAPTER 2
Fanconi Anemia Genes: Structure, Mutations, and Genotype-Phenotype
Correlations 20-33
C) Scientific work
CHAPTER 3
Lack of Sensitivity of Primary Fanconi´s Anemia Fibroblasts towards UV
and Ionizing Irradiation 34-44
CHAPTER 4
Molecular and clinical spectrum of the central Fanconi anemia gene
FANCD2: a series of 32 patients 45-70
CHAPTER 5
Fanconi anemia complementation group FA-L: severe phenotype despite
somatic reversion of the FANCL gene 71-82
CHAPTER 6
The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia 83-89CONTENTS IV
CHAPTER 7
Biallelic mutations in PALB2, which encodes a BRCA2 interacting protein,
cause Fanconi anemia subtype FA-N and predispose to childhood cancer 90-97
CHAPTER 8
Human RAD50 deficiency causes impairment of ATM- and NMR-related
functions 98-109
D) General Discussion 110-114
E) Summary/ Zusammenfassung 115-119
F) Acknowledgement 120
G) Curriculum vitae 121-122
H) Publications/ presentations 123-126
1PREFACE/ OUTLINE
Preface and thesis outline
Basic research involving human chromosomal instability and cancer susceptibility syndromes is
necessary to gain insights into molecular mechanisms which maintain genomic integrity. The focus
of this thesis is directed at the molecular, cellular and clinical aspects of two groups of inherited
diseases that serve as models for the elucidation of causes and consequences of genetic instability.
The genes whose defects cause these diseases are referred to as “caretaker” genes since they appear
to function in the recognition and repair of DNA lesions, most notably DNA double strand breaks.
Mutational inactivation of these genes results in a sharply increased risk of cancer and contributes
to premature aging.
The fi rst of these diseases is Fanconi anemia (FA). Several FA genes have been identifi ed in the last
few years, raising questions regarding cellular phenotype, mutation spectra, frequency, function , and
genotype-phenotype correlations. At the beginning of this thesis only eight of the currently twelve
FA genes had been identifi ed. In close collaboration with the laboratory of Professor Hanenberg
(Düsseldorf) we routinely assigned our FA patients to one of the known complementation groups.
FA cell lines that could not be assigned to one of the known groups were further classifi ed as
defective or profi cient in FANCD2 monoubiquitination, a central process in the FA caretaker
pathway. This allowed to classify these patient cell lines as upstream or downstream partners within
the FA caretaker pathway.
Since defective caretaker genes convey susceptibility to a variety of agents that damage DNA,
primary FA fi broblasts belonging to 7 different complementations groups were initially tested for
their sensitivity regarding ionizing and UV-irradiation. These results were of special interest in the
context of the then newly discovered FANCD2 gene which turned out to play a central role in the
FA/BRCA pathway. As such, the molecular analysis of the FANCD2 gene represents a major part
of this thesis. These studies provided the fi rst comprehensive mutation analysis in the FANCD2
gene, based on a cohort of 32 FA-D2 patients. I was also able to show that FA-D2 patients, despite
their exclusively hypomorphic mutations, are more severely affected than the average FA patient.
In order to be activated, FANCD2 must undergo monoubiquitination by the FANCL ubiquitin
ligase. It was therefore of great interest to detect the worldwide second only FA patient belonging
to complementation group FA-L. As observed with FA-D2 patients, there were no biallelic null-
mutations in our FA-L patient, confi rming the ontogenetic importance of these evolutionarily
conserved genes. FA cell lines who could not be assigned to any of the known complementation
groups were subjected to extensive genetic screens in order to detect the corresponding genes.
These studies were carried out in cooperation with a number of laboratories in the US, UK, Spain
and the Netherlands. As a result of these collaborative projects, I participated in the identifi cation
of FANCJ and FA N C N as novel FA genes. BRIP1/FANCJ was identifi ed by positional cloning using
samples of consanguineous Inuit families under the leadership of Dr. Arleen Auerbach (Rockerfeller
University, NY, USA). FANCN was found in the lab of Dr. Nazneen Rahman (Sussex, UK) using a
candidate gene approach. 2PREFACE/ OUTLINE
In addition to the FA genes, another group of prominent players in the DNA damage response is a
group of genes that includes ATM, ATR and the members of the so-called NMR complex (NBS1/
MRE11/RAD50). Whereas a number of patients with defects in one of the fi rst two members of
the NMR complex are known (i.e. Nijmegen breakage syndrome, and ATM-related syndrome) the
last part of my thesis work concerns the characterization of the worldwide fi rst patient who was
shown to carry biallelic mutations in the RAD50 gene, the third member of the NMR complex. This
patient displayed a clinical phenotyp resembling the Nijmegen breakage syndrome (NBS), however
without any signs of immunodefi ciency. In collaboration with Professor Thilo Dörks group (MHH,
Hannover), I carried out complementation analysis, cell cycle and other functional studies in order
to characterize the molecular, cellular and phenotypic consequences of human RAD50 defi ciency.
The publications reporting the results of my experimental work on the FA and RAD50 genes are
preceeded by copies of two review articles that are meant to introduce the reader to the topic of
human caretaker genes, most notably those causing Fanconi anemia. During the time of my thesis,
I was witness of a virtual explosion of knowledge concerning the role and function of this group of
genes, including their prominent role in the protection against bone marrow failure, leukaemia and
solid tumors. CHAPTER 1
CHAPTER 1
Fanconi anemia: consequences of genetic instability
R. Kalb, K. Neveling, I. Nanda, D. Schindler, H. Hoehn
Department of Human Genetics, University of Würzburg, Biocenter, Würzburg (Germany)
Genome Dynamics Vol. 1, Genome and Disease, Karger Verlag, 2006, pp. 218-2424CHAPTER 1
Abstract
Fanconi anemia (FA) is a rare recessive disease that reflects the cellular and phenotypic
consequences of genetic instability: growth retardation, congenital malformations, bone marrow
failure, high risk of neoplasia, and premature aging. At the cellular level, manifestations of
genetic instability include chromosomal breakage, cell cycle disturbance, and increased somatic
mutation rates. FA cells are exquisitely sensitive towards oxygen and alkylating drugs such as
mitomycin C or dieboxybutane, pointing to a function of FA genes in the defense against reactive
oxygen species and other DNA damaging agents. FA is caused by biallelic mutations in at least
11 different genes which appear to function in the maintenance of genomic stability. Eight of
the FA genes form a nuclear core complex with a catalytic function involving ubiquitination
of the central FANCD2 protein. The posttranslational modification of FANCD2 promotes its
accumulation in nuclear foci, together with known DNA maintenance proteins such as BRCA1,
BRCA2, and the RAD51 recombinase. Biallelic mutations in BRCA2 cause a severe FA-like
phenotype, as do biallelic mutations in FANCD2. In fact, only leaky or hypomorphic mutations
in this central group of FA genes appear to be compatible with live birth and survival. The
newly discovered FANCJ (=BRIP1) and FANCM (=Hef) genes correspond to known DNA-
maintenance genes (helicase resp. helicase-associated endonuclease for fork-structured DNA).
These genes provide the most convincing evidence to date of a direct involvement of FA genes
in DNA repair functions associated with the resolution of DNA crosslinks and stalled replication
forks. Even though genetic instability caused by mutational inactivation of the FANC genes has
detrimental effects for the majority of FA patients, around 20% of patients appear to benefit
from genetic instability since genetic instability also increases the chance of somatic rever